Immune to Cancer: The CRI Blog
-
Breaking Through: 2014 Annual Report Highlights
Discover why this past year was one of many breakthroughs for the Cancer Research Institute with our…
-
FDA Approves New Immunotherapy for Leukemia
Amgen’s Blincyto was approved by the FDA, making it the first approved bispecific T cell engaging (BiTE)…
-
Wall Street Journal Article Profiles Cancer Immunotherapy ‘Super Survivors’
Cancer Research Institute scientists, and the patients they have treated, are the subject of a new article…
-
#GivingTuesday Breaks Record for Breakthrough Research
Cancer Research Institute extends a heartfelt thank you to our supporters who helped raise over $96,000 for…
-
Immunotherapy Featured on NBC Sports
Leukemia survivor Milton Wright highlighted during Thanksgiving's 49ers vs. Seahawks half-time show.
-
Immunotherapy for Blood Cancers: What to Look for at the Upcoming ASH Meeting
Look for the latest results from trials of PD-1 inhibitors and new developments in adoptive cell transfer.
-
Found: A Molecular Needle in the Cancer Haystack
New research by CRI scientists shows how genomic methods can be used to create a personalized cancer…
-
Birth of the Lab Mouse
Was the father of cancer immunotherapy also the father of the modern lab mouse?
-
CAR T Cell Therapy Surges Forward
Researchers at the University of Pennsylvania publish latest results on an experimental immunotherapy using genetically engineered T…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.